Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: A Randomized Controlled Trial in Patients Hospitalized With Heart Failure - HORIZON-HF


The goal of the trial was to evaluate istaroxime, an inotropic and lusitropic agent, compared with placebo in hospitalized patients with acute heart failure (HF).